T1	Participants 107 158	bone marrow of patients with acute myeloid leukemia
T2	Participants 463 512	In 32 patients with newly diagnosed untreated AML
T3	Participants 649 668	10 control patients
T4	Participants 836 886	patients with a high degree of microvessel density
T5	Participants 912 922	low degree
T6	Participants 1080 1155	patients who achieved a complete remission following induction chemotherapy
T7	Participants 1373 1385	AML patients
